Despite the higher mortality induced by AAA modeling in female mice than that in male mice, our results showed that the diameter of aneurysms was significantly reduced and the survival rate was increased in the mice supplemented with recombinant FAM3A compared to those in the matched control mice (Supplementary Fig. 3a, b). This evidence concerns the gene FAM3A and triple-A syndrome.